A review of the psychomotor effects of paroxetine
- PMID: 1431014
- DOI: 10.1097/00004850-199206004-00012
A review of the psychomotor effects of paroxetine
Abstract
Studies on the behavioural effects of paroxetine on healthy young volunteers, elderly volunteers, and patients suffering from major depressive illness failed to show any evidence of detrimental effects on a battery of objective and subjective measures even when alcohol was taken. In contrast, the chosen verum, amitriptyline or lorazepam, produced significant impairment. The study on depressed patients showed improvement in cognitive functions among the paroxetine group from the start, whereas these functions were, initially, significantly impaired in the dothiepin group. Moreover, the Leeds Sleep Evaluation Questionnaire indicated that dothiepin produced, with respect to paroxetine, a significantly poorer quality of sleep.
Similar articles
-
The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly.Int Clin Psychopharmacol. 1992 Nov;7(2):101-8. Int Clin Psychopharmacol. 1992. PMID: 1487621 Clinical Trial.
-
Sleep and paroxetine: a comparison with mianserin in elderly depressed patients.Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:53-8. Int Clin Psychopharmacol. 1992. PMID: 1431012 Clinical Trial.
-
Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers.Eur Neuropsychopharmacol. 1995 Mar;5(1):35-42. doi: 10.1016/0924-977x(94)00130-4. Eur Neuropsychopharmacol. 1995. PMID: 7613099 Clinical Trial.
-
The safety profile of paroxetine.J Clin Psychiatry. 1992 Feb;53 Suppl:61-6. J Clin Psychiatry. 1992. PMID: 1531828 Review.
-
Paroxetine: a review of clinical experience.Pharmacopsychiatry. 1998 May;31(3):89-101. doi: 10.1055/s-2007-979307. Pharmacopsychiatry. 1998. PMID: 9657236 Review.
Cited by
-
Effective and acceptable treatment for depression.BMJ. 1993 Apr 24;306(6885):1126; author reply 1126-7. doi: 10.1136/bmj.306.6885.1126-a. BMJ. 1993. PMID: 8495172 Free PMC article. No abstract available.
-
Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.Drug Saf. 1998 Mar;18(3):189-208. doi: 10.2165/00002018-199818030-00004. Drug Saf. 1998. PMID: 9530538 Review.
-
Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.Pharmacoeconomics. 1997 Jun;11(6):515-37. doi: 10.2165/00019053-199711060-00002. Pharmacoeconomics. 1997. PMID: 10168093 Review.
-
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.Drugs. 1998 Jan;55(1):85-120. doi: 10.2165/00003495-199855010-00007. Drugs. 1998. PMID: 9463792 Review.
-
Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.Drugs Aging. 1997 Aug;11(2):119-31. doi: 10.2165/00002512-199711020-00004. Drugs Aging. 1997. PMID: 9259175 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources